Invivogen
Menu

InvivoGen's product citations

Citations

InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).

Citations search

You can search by ‘Product Name’ or ‘Year’.

Find a citation by product name
Enter a year of publication
Product Citation Year Journal Authors Page
Primocin® Supplemental Material: IL-20 controls resolution of experimental colitis by r... 2023 Gut Chiriac M.T. et al. DOI: 10.1136/gutjnl-2023-329628
NLRP3 inflammasome inhibitor - MCC950 E-selectin-mediated rapid NLRP3 inflammasome activation regulates S100A8/S100... 2023 Nat Immunol. Pruenster M. et al. DOI: 10.1038/s41590-023-01656-1
Caspase-1 and Caspase-4 inhibitor E-selectin-mediated rapid NLRP3 inflammasome activation regulates S100A8/S100... 2023 Nat Immunol. Pruenster M. et al. DOI: 10.1038/s41590-023-01656-1
Nigericin E-selectin-mediated rapid NLRP3 inflammasome activation regulates S100A8/S100... 2023 Nat Immunol. Pruenster M. et al. DOI: 10.1038/s41590-023-01656-1
RAW-Lucia™ ISG-KO-STING Cells Synergistic Effects of Azithromycin and STING Agonist Promote IFN-I Productio... 2023 J Exp Pharmacol. Petcharat K. et al. DOI: 10.2147/JEP.S433181
DMXAA Synergistic Effects of Azithromycin and STING Agonist Promote IFN-I Productio... 2023 J Exp Pharmacol. Petcharat K. et al. DOI: 10.2147/JEP.S433181
Normocin® - Antimicrobial Reagent Synergistic Effects of Azithromycin and STING Agonist Promote IFN-I Productio... 2023 J Exp Pharmacol. Petcharat K. et al. DOI: 10.2147/JEP.S433181
RAW-Lucia™ ISG Cells Synergistic Effects of Azithromycin and STING Agonist Promote IFN-I Productio... 2023 J Exp Pharmacol. Petcharat K. et al. DOI: 10.2147/JEP.S433181
QUANTI-Luc™: Luciferase Detection Reagent Synergistic Effects of Azithromycin and STING Agonist Promote IFN-I Productio... 2023 J Exp Pharmacol. Petcharat K. et al. DOI: 10.2147/JEP.S433181
CD40L Reporter HEK 293 Cells Unbiased assessment of genome integrity and purging of adverse outcomes at th... 2023 EMBO J. Canarutto D. et al. DOI: 10.15252/embj.2023114188
Recombinant human CD40L protein Unbiased assessment of genome integrity and purging of adverse outcomes at th... 2023 EMBO J. Canarutto D. et al. DOI: 10.15252/embj.2023114188
Anti-hIL-1β-IgG Unbiased assessment of genome integrity and purging of adverse outcomes at th... 2023 EMBO J. Canarutto D. et al. DOI: 10.15252/embj.2023114188
Anti-TNF-α (Adalimumab biosimilar - IgG1 isotype) Unbiased assessment of genome integrity and purging of adverse outcomes at th... 2023 EMBO J. Canarutto D. et al. DOI: 10.15252/embj.2023114188
QUANTI-Blue™ Unbiased assessment of genome integrity and purging of adverse outcomes at th... 2023 EMBO J. Canarutto D. et al. DOI: 10.15252/embj.2023114188
MycoStrip® - Mycoplasma Detection Kit Novel Indolyl-Benzimidazole Compounds Promote in vitro Wound Healing and Oste... 2023 Front Biosci (Landmark Ed). Najafi S. et al. DOI: 10.31083/j.fbl2810268
Caspase-1 and Caspase-4 inhibitor Attenuates reactive oxygen species: induced pyroptosis via activation of the ... 2023 Sci Rep. Liu M. et al. DOI: 10.1038/s41598-023-44013-w
Puromycin The inhibitory effect of Gremlin-2 on adipogenesis suppresses breast cancer c... 2023 Breast Cancer Res. Jung J. et al. DOI: 10.1186/s13058-023-01732-2
Puromycin Developing synthetic tools to decipher the tumor-immune interactome. 2023 PNAS Weizman O.E. et al. DOI: 10.1073/pnas.2306632120
Blasticidin Developing synthetic tools to decipher the tumor-immune interactome. 2023 PNAS Weizman O.E. et al. DOI: 10.1073/pnas.2306632120
G418 (Geneticin) Developing synthetic tools to decipher the tumor-immune interactome. 2023 PNAS Weizman O.E. et al. DOI: 10.1073/pnas.2306632120

Pages

Customer Service
& Technical Support
Contact us
Shopping cart is empty